[HTML][HTML] Metformin clinical trial in HPV+ and HPV–head and neck squamous cell carcinoma: impact on cancer cell apoptosis and immune infiltrate
Background: Metformin, an oral anti-hyperglycemic drug which inhibits mitochondrial
complex I and oxidative phosphorylation has been reported to correlate with improved …
complex I and oxidative phosphorylation has been reported to correlate with improved …
[PDF][PDF] Metformin Clinical Trial in HPV+ and HPV–Head and Neck Squamous Cell Carcinoma: Impact on Cancer Cell Apoptosis and Immune Infiltrate. Front
JM Curry, J Johnson, M Mollaee, P Tassone, D Amin… - Oncol, 2018 - academia.edu
Background: Metformin, an oral anti-hyperglycemic drug which inhibits mitochondrial
complex I and oxidative phosphorylation has been reported to correlate with improved …
complex I and oxidative phosphorylation has been reported to correlate with improved …
Metformin Clinical Trial in HPV+ and HPV-Head and Neck Squamous Cell Carcinoma: Impact on Cancer Cell Apoptosis and Immune Infiltrate.
JM Curry, J Johnson, M Mollaee, P Tassone… - Frontiers in …, 2018 - europepmc.org
Background: Metformin, an oral anti-hyperglycemic drug which inhibits mitochondrial
complex I and oxidative phosphorylation has been reported to correlate with improved …
complex I and oxidative phosphorylation has been reported to correlate with improved …
Metformin Clinical Trial in HPV+ and HPV-Head and Neck Squamous Cell Carcinoma: Impact on Cancer Cell Apoptosis and Immune Infiltrate.
JM Curry, J Johnson, M Mollaee, P Tassone, D Amin… - 2018 - jdc.jefferson.edu
Background: Metformin, an oral anti-hyperglycemic drug which inhibits mitochondrial
complex I and oxidative phosphorylation has been reported to correlate with improved …
complex I and oxidative phosphorylation has been reported to correlate with improved …
Metformin Clinical Trial in HPV+ and HPV-Head and Neck Squamous Cell Carcinoma: Impact on Cancer Cell Apoptosis and Immune Infiltrate
JM Curry, J Johnson, M Mollaee… - Frontiers in …, 2018 - pubmed.ncbi.nlm.nih.gov
Background: Metformin, an oral anti-hyperglycemic drug which inhibits mitochondrial
complex I and oxidative phosphorylation has been reported to correlate with improved …
complex I and oxidative phosphorylation has been reported to correlate with improved …
[PDF][PDF] Metformin Clinical Trial in HPV+ and HPV–Head and Neck Squamous Cell Carcinoma: Impact on Cancer Cell Apoptosis and Immune Infiltrate. Front
JM Curry, J Johnson, M Mollaee, P Tassone, D Amin… - Oncol, 2018 - core.ac.uk
Background: Metformin, an oral anti-hyperglycemic drug which inhibits mitochondrial
complex I and oxidative phosphorylation has been reported to correlate with improved …
complex I and oxidative phosphorylation has been reported to correlate with improved …
[HTML][HTML] Metformin Clinical Trial in HPV+ and HPV–Head and Neck Squamous Cell Carcinoma: Impact on Cancer Cell Apoptosis and Immune Infiltrate
JM Curry, J Johnson, M Mollaee, P Tassone… - Frontiers in …, 2018 - ncbi.nlm.nih.gov
Background: Metformin, an oral anti-hyperglycemic drug which inhibits mitochondrial
complex I and oxidative phosphorylation has been reported to correlate with improved …
complex I and oxidative phosphorylation has been reported to correlate with improved …
[PDF][PDF] Metformin Clinical Trial in HPV+ and HPV–Head and Neck Squamous Cell Carcinoma: Impact on Cancer Cell Apoptosis and Immune Infiltrate. Front
JM Curry, J Johnson, M Mollaee, P Tassone, D Amin… - Oncol, 2018 - core.ac.uk
Background: Metformin, an oral anti-hyperglycemic drug which inhibits mitochondrial
complex I and oxidative phosphorylation has been reported to correlate with improved …
complex I and oxidative phosphorylation has been reported to correlate with improved …